Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

European Expansion of moveUP

Project description

The making of a European mobile health platform

In recent years, most sectors have shifted to or expanded to accommodate a digital infrastructure. In line with this trend, moveUP developed a mobile health platform that allows patients to be informed and treated using standardised and validated protocols. It can provide more effective and reproducible therapies for joint replacements that show better results than those of standard care. Its use was initially intended for orthopaedics, but the global Covid-19 pandemic has signalled the need to cover other medical fields. However, due to the fragmented state of the European healthcare market, moveUP has not been able to expand. The EU-funded EXPANSE project will reverse this trend by adapting and certifying moveUP’s digital therapy in four countries, using large-scale pilots to introduce it to the market.

Objective

2020 will be remembered as year zero of tele-medicine. moveUP has developed a mobile health platform that monitors, informs and treats patients via standardised & validated protocols. Its first product is in orthopaedics, but with the Corona Crisis and the cancellation of all elective procedures, the platform has been extended to other pathologies. On 18/03, a monitoring protocol of suspected Covid19 patients has been offered to General Practitioners (GP), enabling them to follow-up symptoms of hundreds of patients, and intervene in case of need. The topic of this program remains orthopaedic joint replacements. But the benefits of the solution and its applicability for infectious or disabling diseases which restricts movement to the GP will be clear to the reader. Joint replacements are referred to as the surgery of the century, as the number are growing exponentially. But 20-30% of patients remain unsatisfied and quality of care is not measured. moveUP offers patients a safe, efficient and qualitative therapy to be made from the comfort of their home. It uses medical device certified machine learning models to adapt activity level, exercises, medication and coach patients, under uner supervision of healthcare providers. The therapy has shown in clinical studies to offer excellent outcomes, lower variability, and objective measure of quality, at a lower cost compared to standard of care. More than 1200 patients have been treated and it is the first digital therapy fully reimbursed by the national health insurance in Belgium. moveUP and has taken first steps to expand across Europe. But the fragmentation of the European Healthcare markets makes it more difficult for a start-up to scale and raise funding. The purpose of this application is to enable moveUP to adapt and certify its therapy in 4 target countries, run large scale pilots to demonstrate efficacy and health economic benefit, and to conclude partnerships with strategic partners to gain scale.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

SME - SME instrument

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

MOVEUP
Net EU contribution
€ 1 336 637,00
Address
CANTERSTEEN 47
1000 BRUXELLES
Belgium
SME
Yes
Region
Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 587 625,00

Participants (2)